Literature DB >> 14970791

Ocular torsion: rotations around the "WHY" axis.

Burton J Kushner1.   

Abstract

BACKGROUND: Traditional teaching holds that there is a partial compensatory countertorsion after head tilt because the intorters in the eye on the side of the head tilt and the extorters in the contralateral eye are stimulated. This teaching is inconsistent with a number of clinical observations.
METHODS: Review of existing literature, reanalysis of data from the investigator's previous experiments, and inductive and deductive reasoning were used to reconcile inconsistencies and present a theory on why torsional movements occur.
RESULTS: The inconsistencies can be reconciled if one considers that during the dynamic phase of head tilt, there is an alternating series of intorsional and extorsional movements of both eyes. Each eye has slow dynamic compensatory counterrolling phases that serve as torsional "doll's-head" movements to stabilize the image during head tilt. This counterrolling is partially eliminated by a series of anticompensatory torsional saccades in the direction of head tilt, which is in contrast to traditional teaching.
CONCLUSION: Dynamic compensatory counterrolling occurs during head tilt. It is largely eliminated by anticompensatory torsional saccades in the opposite direction so that by the end of head tilt only minimal static countertorsion remains. The dynamic compensatory counterrolling motion is necessary to minimize peripheral visual movement during head tilt. The elimination of most of the counterrolling by the end of head tilt is necessary to preserve convergence and stereopsis.

Mesh:

Year:  2004        PMID: 14970791     DOI: 10.1016/j.jaapos.2003.09.004

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  12 in total

1.  Static ocular counterroll: video-based analysis after minimizing the false-torsion factors.

Authors:  Ichiro Hamasaki; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

2.  Gillies Lecture: ocular motility in a time of paradigm shift.

Authors:  Joseph L Demer
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

Review 3.  Mechanics of the orbita.

Authors:  Joseph L Demer
Journal:  Dev Ophthalmol       Date:  2007

4.  Functional imaging of human extraocular muscles in head tilt dependent hypertropia.

Authors:  Joseph L Demer; Jennifer Kung; Robert A Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-09       Impact factor: 4.799

5.  Effects of inferior oblique muscle-weakening surgery on the Bielschowsky head-tilt phenomenon in patients with superior oblique palsy habitually fixating with the paretic eye.

Authors:  Fumiko Kishimoto; Satoshi Hasebe; Hiroshi Ohtsuki
Journal:  Jpn J Ophthalmol       Date:  2011-06-24       Impact factor: 2.447

6.  Enhanced vertical rectus contractility by magnetic resonance imaging in superior oblique palsy.

Authors:  Robert A Clark; Joseph L Demer
Journal:  Arch Ophthalmol       Date:  2011-07

7.  Effects of intracranial trochlear neurectomy on the structure of the primate superior oblique muscle.

Authors:  Joseph L Demer; Vadims Poukens; Howard Ying; Xiaoyan Shan; Jing Tian; David S Zee
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

8.  Effect of diagnostic occlusion in acquired trochlear nerve palsy.

Authors:  Michael Gräf; Johannes Weihs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-23       Impact factor: 3.117

9.  Superior oblique tucking with versus without additional inferior oblique recession for acquired trochlear nerve palsy.

Authors:  Michael Gräf; Birgit Lorenz; Anja Eckstein; Joachim Esser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-17       Impact factor: 3.117

10.  Absence of relationship between oblique muscle size and bielschowsky head tilt phenomenon in clinically diagnosed superior oblique palsy.

Authors:  Reika Kono; Hirotaka Okanobu; Hiroshi Ohtsuki; Joseph L Demer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.